Effects of thyroid hormones on human breast cancer cell proliferation

被引:136
作者
Hall, Linda C. [2 ]
Salazar, Eddie P. [1 ]
Kane, Staci R. [2 ]
Liu, Nan [1 ]
机构
[1] Lawrence Livermore Natl Lab, Biosci Directorate, Livermore, CA 94550 USA
[2] Lawrence Livermore Natl Lab, Safety & Environm Protect Directorate, Livermore, CA 94550 USA
关键词
thyroid hormone; breast cancer; cell proliferation; gene expression;
D O I
10.1016/j.jsbmb.2007.12.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The involvement of estrogens in breast cancer development and growth has been well established. However, the effects of thyroid hormones and their combined effects with estrogens are not well studied. We investigated the response of human breast cancer cells to thyroid hormone, particularly the role of T3 in mediating cell proliferation and gene expression. We demonstrated that 17 beta-estradiol (E2) or triiodothyronine (T3) promoted cell proliferation in a dose-dependent manner in both MCF-7 and T47-D cell lines. The E2- or T3-dependent cell proliferation was suppressed by co-administration of the ER antagonist ICI. We also demonstrated that T3 could enhance the effect of E2 on cell proliferation in T47-D cells. Using an estrogen response element (ERE)-mediated luciferase assay, we determined that T3 was able to induce the activation of ERE-mediated gene expression in MCF-7 cells, although the effects were much weaker than that induced by E2. These results suggest that T3 can promote breast cancer cell proliferation and increase the effect of E2 on cell proliferation in some breast cancer cell lines and thus that T3 may play a role in breast cancer development and progression. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 41 条
[1]   Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-α protein:: Estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary [J].
Alarid, ET ;
Preisler-Mashek, MT ;
Solodin, NM .
ENDOCRINOLOGY, 2003, 144 (08) :3469-3476
[2]   Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity [J].
Barrera-Hernandez, G ;
Park, KS ;
Dace, A ;
Zhan, QM ;
Cheng, SY .
ENDOCRINOLOGY, 1999, 140 (11) :5267-5274
[3]   The retinoblastoma protein pathway in cell cycle control and cancer [J].
Bartek, J ;
Bartkova, J ;
Lukas, J .
EXPERIMENTAL CELL RESEARCH, 1997, 237 (01) :1-6
[4]   Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions [J].
Bassett, JHD ;
Harvey, CB ;
Williams, GR .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 213 (01) :1-11
[5]   Estrogen actions in the ovary revisited [J].
Britt, KL ;
Findlay, JK .
JOURNAL OF ENDOCRINOLOGY, 2002, 175 (02) :269-276
[6]   Risk factors for breast cancer according to estrogen and progesterone receptor status [J].
Colditz, GA ;
Rosner, BA ;
Chen, WY ;
Holmes, MD ;
Hankinson, SE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (03) :218-228
[7]   Influence of thyroid hormone receptors on breast cancer cell proliferation [J].
Conde, I ;
Paniagua, R ;
Zamora, J ;
Blánquez, MJ ;
Fraile, B ;
Ruiz, A ;
Arenas, MI .
ANNALS OF ONCOLOGY, 2006, 17 (01) :60-64
[8]  
Cotterchio M, 2003, CANCER EPIDEM BIOMAR, V12, P1053
[9]  
Couse JF, 2001, ANN NY ACAD SCI, V948, P1
[10]   Thyroid hormone and breast carcinoma - Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma [J].
Cristofanilli, M ;
Yamamura, Y ;
Kau, SW ;
Bevers, T ;
Strom, S ;
Patangan, M ;
Hsu, LM ;
Krishnamurthy, S ;
Theriault, RL ;
Hortobagyi, GN .
CANCER, 2005, 103 (06) :1122-1128